Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 89Thoracic 39Head & Neck 24Breast 15Lymphoid 11Sarcoma 10Gynecologic 10Dermatologic 6Other solid neoplasm 5CNS 5Genitourinary 3Other neoplasm 1Other hematologic neoplasm 1

Conditions

Esophageal Malignant Neoplasm, Local Recurrence 1

Interventions

Cyclophosphamide 5Decitabine 3Carboplatin 3Busulfan 3Radiotherapy 2Endoscopy 2Chemoradiotherapy 2Capecitabine 2sintilimab 1sargramostim 1liposomal doxorubicin 1fludarabine phosphate 1exemestane 1camrelizumab 1alethine 1Watchful Waiting 1Vincristine 1Ultrasonography, Doppler 1Rifampin 1Proton Therapy 1Polymerase Chain Reaction 1Patient Reported Outcome Measures 1Papanicolaou Test 1Paclitaxel 1Observation 1Mycophenolic Acid 1Methylation 1Mass Spectrometry 1Liver Transplantation 1Laparoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × camrelizumab × Other neoplasm × Clear all
NCT04404491 2020-05-27

Clinical Control Study of Immunotherapy and Concurrent Chemoradiotherapy in Patients With Esophageal Cancer Recurrence

The First Affiliated Hospital of Henan University of Science and Technology

Phase 3 Unknown
240 enrolled
GastrointestinalOther neoplasm

Esophageal Malignant Neoplasm, Local Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡